Brian M. Gallagher has joined the board of directors of Framingham-based Transport Pharmaceuticals Inc.
Gallagher is currently president and CEO of Magen Biosciences, a dermatology-focused specialty pharmaceutical company.
Gallagher held executive positions at Bristol-Meyers Squibb, worked at other specialty pharmaceutical companies, and as a consultant before joining Magen.
Transport makes combination drug/medical devices for the topical treatment of dermatological conditions.
